Schedule H Prescription Drug. Dispensed strictly on valid registered medical prescription.
PMBJP Generic Available
Manufacturer: Indian Pharmaceutical Formulary
Voveran 50 — Diclofenac Sodium IP / BP / USP (Tablet)
Clinical guide for Voveran 50 (Diclofenac): indications, dosage, side effects, PMBJP Jan Aushadhi generic at ₹7.50 (save 91%), and substitutes.
Statutory Clinical Notice: This clinical monograph is formulated under Indian Pharmacopoeia (IP) and CDSCO regulatory frameworks for verified educational and generic substitution purposes. Do not modify prescription drug therapy without formal clinical authorization from a Registered Medical Practitioner.
Pharmacological & Regulatory Specifications
| Active Salt Pharmacopoeia | Diclofenac Sodium IP / BP / USP | IUPAC Chemical Name | sodium 2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetate |
|---|---|---|---|
| Therapeutic Class | Phenylacetic Acid Non-Steroidal Anti-Inflammatory Drug (NSAID) | WHO ATC Code | M01AB05 |
| CDSCO Schedule | Schedule H Prescription Drug. Dispensed strictly on valid registered medical prescription. | Pregnancy Risk Category | Category D in third trimester (US FDA) / Category C in first and second trimesters. Ingestion during late pregnancy is strictly contraindicated due to premature closure of the fetal ductus arteriosus, persistent pulmonary hypertension, and prolonged labor. |
| Meal Timing Instruction | Take after meals with water | Storage Conditions | Store below 25°C away from direct sunlight & moisture |
Biochemical Mechanism of Action (MoA)
Potent non-steroidal anti-inflammatory drug (NSAID) with pronounced analgesic, antipyretic, and anti-inflammatory properties. Non-selectively inhibits cyclooxygenase enzymes (COX-1 and COX-2) with slight preferential selectivity for COX-2. By inhibiting COX, it halts the synthesis of pro-inflammatory prostaglandins (PGE2, PGF2alpha, PGI2) and thromboxane A2 from arachidonic acid. Decreased PGE2 synthesis reduces the sensitization of peripheral nociceptive nerve endings to bradykinin and histamine, suppresses local vasodilation and tissue edema, and resets the hypothalamic thermoregulatory set-point. At high concentrations, diclofenac also suppresses leukocyte migration, reduces intracellular arachidonate availability, and partially inhibits the 5-lipoxygenase pathway.
Branded MRP vs. PMBJP Jan Aushadhi Generic Price Comparison
| Formulation Tier | Manufacturer / Formulary | Retail Price (Strip) | Patient Savings | Quality Standard |
|---|---|---|---|---|
| Voveran 50 (Branded) | Indian Pharmaceutical Formulary | ₹85.00 | Baseline MRP | Commercial Retail IP |
| PMBJP Jan Aushadhi Generic | BPPI / Govt. of India | ₹7.50 | Save 91% | NABL Tested Bioequivalent IP |
* Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) generic formulations are manufactured in WHO-GMP certified facilities and tested at NABL-accredited analytical laboratories to ensure 100% bioequivalent plasma concentration curves (AUC 80–125%).
4 Bioequivalent Indian Brand Substitutes
| Brand Name | Manufacturer | Active Pharmaceutical Salt | Retail MRP | Bioequivalence Status |
|---|---|---|---|---|
| Voveran 50 | Novartis / Dr. Reddy's Laboratories Ltd | Diclofenac Sodium IP / BP / USP | ₹84.00 | Bioequivalent NABL IP |
| Dynapar 50 | Troikaa Pharmaceuticals Ltd | Diclofenac Sodium IP / BP / USP | ₹78.00 | Bioequivalent NABL IP |
| Reactin 50 | Cipla Ltd | Diclofenac Sodium IP / BP / USP | ₹72.00 | Bioequivalent NABL IP |
| Dicloran 50 | J.B. Chemicals & Pharmaceuticals Ltd | Diclofenac Sodium IP / BP / USP | ₹68.00 | Bioequivalent NABL IP |
Organ-System Grouped Adverse Effects
| Physiological System | Documented Clinical Adverse Manifestations |
|---|---|
| gastrointestinal | Dyspepsia, epigastric pain, heartburn, and nausea; Gastric and duodenal mucosal ulceration, perforation, and bleeding; Diarrhea, constipation, flatulence, and vomiting |
| central Nervous | Headache, dizziness, and lightheadedness; Somnolence, tinnitus, and vertigo; Aseptic meningitis (rare) |
| dermatological | Pruritus, cutaneous rash, and urticaria; Photosensitivity and erythema multiforme; Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN / rare) |
| hepatorenal | Serum transaminase elevations (ALT/AST >3x ULN in approx. 2-4% of patients; diclofenac carries the highest risk of drug-induced hepatotoxicity among common NSAIDs); Fluid retention, peripheral dependent edema, and sodium retention; Acute kidney injury, renal papillary necrosis, and acute interstitial nephritis |
| cardiovascular | Elevated arterial blood pressure (blunting antihypertensive therapy); Increased risk of serious arterial thrombotic events, myocardial infarction, and stroke (cardiovascular risk profile similar to selective COX-2 inhibitors); Exacerbation of congestive heart failure |
Drug, Food & CYP450 Enzyme Interactions
Metabolizing Enzyme Pathways:
Extensively metabolized in the liver (approx. 50% first-pass clearance) primarily by CYP2C9 to 4'-hydroxydiclofenac, with minor contributions from CYP3A4 and UGT2B7 glucuronidation.
High-Risk Drug Interactions:
- Voriconazole and Fluconazole: Strong CYP2C9 inhibitors that substantially elevate diclofenac plasma concentrations and AUC, compounding gastric and hepatorenal toxicity
- Oral Anticoagulants and Antiplatelets (Warfarin, Aspirin, Clopidogrel): Synergistic impairment of platelet plug formation and gastric barrier integrity, dramatically multiplying major gastrointestinal bleeding risks
- ACE Inhibitors, ARBs, and Diuretics: NSAIDs blunt renal prostacyclin vasodilation, precipitating acute renal failure and reducing blood pressure control
- Lithium and Methotrexate: Diclofenac reduces renal tubular clearance of lithium and methotrexate, leading to elevated serum concentrations and severe toxicity
- Cyclosporine and Tacrolimus: Additive renal vasoconstriction, escalating nephrotoxicity
Food & Dietary Guidelines:
STRICT POST-MEAL INGESTION: Must always be swallowed immediately after food with a full glass of water or milk to buffer the gastric lining against direct acidic erosion,Enteric Coating Integrity: Swallow gastro-resistant tablets whole; do not crush, chew, or split the tablet
Frequently Asked Questions (Clinical & Regulatory)
Why should Diclofenac always be taken strictly after food?
Diclofenac is an acidic NSAID that damages the gastric lining in two ways: it directly burns gastric epithelial cells upon contact, and it circulates in the blood to block COX-1 enzymes, stopping the production of protective stomach mucus and bicarbonate. Taking the tablet immediately after meals coats and buffers the stomach, significantly reducing heartburn, nausea, and ulceration.
Why does Diclofenac carry a higher heart attack risk than other NSAIDs like Naproxen?
Diclofenac exhibits a chemical preference for inhibiting the COX-2 enzyme over COX-1, closely resembling the selective coxib drugs. This creates an imbalance by suppressing vasodilatory prostacyclin (PGI2) more than pro-thrombotic thromboxane (TXA2), promoting arterial vasoconstriction and platelet clot formation. Large clinical trials show it carries the highest cardiovascular risk among traditional NSAIDs.
Why do doctors monitor liver enzymes in patients taking Diclofenac?
Diclofenac carries the highest incidence of drug-induced liver injury among common NSAIDs, causing significant transaminase elevations (ALT/AST >3x normal) in approximately 2% to 4% of patients. In rare cases, it can cause severe toxic hepatitis. Patients on long-term therapy should have liver function tested periodically.
Can Voveran gastro-resistant tablets be crushed or chewed?
No, Voveran tablets feature an acid-resistant enteric polymer coating designed to pass through the harsh gastric acid intact, dissolving only when reaching the neutral pH of the small intestine. Chewing or crushing the tablet destroys this protective barrier, releasing the acidic drug directly onto the stomach lining where it causes severe mucosal burning.
Why is Diclofenac strictly forbidden in the third trimester of pregnancy?
Diclofenac crosses the placenta and inhibits prostaglandins that keep the fetal ductus arteriosus open. Taking it after week 28 of pregnancy can cause premature in utero closure of the ductus arteriosus, resulting in fatal fetal heart failure and pulmonary hypertension. It also impairs fetal kidney filtration, leading to oligohydramnios.
Is PMBJP Jan Aushadhi generic Diclofenac 50 bioequivalent to Voveran 50?
Yes, PMBJP Jan Aushadhi Diclofenac Sodium 50 mg gastro-resistant tablets comply with Indian Pharmacopoeia standards and are produced under WHO-GMP certified controls. They provide identical enteric-coating stability, equivalent intestinal dissolution kinetics, and matching analgesic relief compared to Voveran 50 and Dynapar 50 at a 91% cost savings.
💊 दवा की जानकारी — Voveran 50 (Hindi / Hinglish Quick Guide)
उपयोग (Uses): Voveran 50 (Diclofenac Sodium IP / BP / USP) का मुख्य उपयोग Osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis और Acute gouty arthritis and acute bursitis/tendinitis से राहत पाने और डॉक्टर द्वारा निर्धारित चिकित्सीय स्थितियों के उपचार के लिए किया जाता है।
खुराक (Dosage): वयस्कों के लिए खुराक चिकित्सक के परामर्श अनुसार ली जानी चाहिए। दवा को नियमित समय पर पानी के साथ लें।
दुष्प्रभाव (Side Effects): सामान्य रूप से यह दवा सुरक्षित है, परंतु पेट में हल्का दर्द या मतली हो सकती है। कोई भी गंभीर लक्षण दिखने पर तत्काल चिकित्सक से संपर्क करें।
जन औषधि विकल्प (Jan Aushadhi Generic Savings): यही साल्ट प्रधानमंत्री भारतीय जन औषधि केंद्र पर मात्र ₹7.50 में उपलब्ध है, जिससे आप ब्रांडेड दवा की तुलना में 91% तक की सीधी बचत कर सकते हैं।
MediMatch AI Clinical Governance & Statutory Formulary Citations
This monograph was evaluated by the MediMatch AI Clinical Pharmacology Review Board in accordance with National Formulary of India (NFI) and Indian Pharmacopoeia standards.
Digital Personal Data Protection (DPDP) Act 2023 & Emergency Notice: MediMatch AI does not store identifiable personal health records without explicit consent. For acute medical emergencies or adverse poisoning incidents, immediately dial national emergency services at 112 or visit the nearest emergency medical facility.